Bridgewater Chapter Upcoming Events Join PCCI

Monday, March 9, 2009

Embassy Suites, Chesterbrook, Pennsylvania (directions)



A Medical Device Company

Presenter: Mike Dugery, President and CEO of Sonomedix



SonoMedix is an early-stage, privately held medical device company located near Philadelphia, PA. SonoMedix's initial product, EZ- INR, is an easy to use blood coagulation (PT/INR) test system for use by patients and healthcare professionals in the management of warfarin therapy. Warfarin, also sold as Coumadin, is the only oral anticoagulation, or blood thinning drug given to patients with Atrial Fibrillation (Afib), Venous Thromboembolism (VTE) or Mechanical Heart Valves (MHV) to prevent the formation of blood clots. An estimated three million people in the US take warfarin daily and while it is the most prescribed anticoagulant next to aspirin, the consequences to the patient of being outside the safe therapeutic range can be severe and life threatening


The EZ-INR System is based on a proprietary Nano-Acoustic Blood Analyzer (NABA) technology. The EZ-INR System consists of a handheld test meter and disposable test strips. The NABA sensor is built into the disposable test strip, creating the "razor & blades" revenue model. The NABA system is based on nano-acoustic interfacial sensing technology, which is capable of detecting blood properties at nano and micro-scales, essentially at the molecular level. Because it uses a fundamentally different means of detecting blood properties than other existing techniques, it has key competitive advantages of being faster, more accurate and requiring a smaller blood sample than anything on the market or in commercial development. The handheld meter will contain the measurement and control electronics, providing both a direct display of the test results, as well as wireless communication for patient database management and billing.



3 Major Issues


  1. Would it be beneficial for the pharma companies that market Warfarin to promote and support patient self testing for PT/INR to keep those patients in their safe therapeutic range?

  2. Reviewing the "Value Chain" slide and given the significant CMS reimbursement dollars garnered by the Independent Diagnostic Testing Facility (IDTF), should Sonomedix expand its business model to include the IDTF function?

  3. Funding options?





6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)

8:00 - Mike Dugery, President and CEO of Sonomedix will deliver the Company's "Elevator" Pitch to the Group

8:15 - A Panel will address 3 Major Issues for the Company

9:00 - Open discussion: members and guests



<Top of the page>





Available Media

Please note: All information obtained here is the property of those presenting and should not be copied or duplicated without written consent.



None available at this time


None available at this time


None available at this time


SonoMedix Webcast 03/11/09

Contact Info:

Mike Dugery

CEO, Sonomedix, Inc

16 Townview Drive, Suite 201

Doylestown, PA 18901

Tel: 215-534-2481



List of Attendees

Akerblom, Ulf

Bell, Caroline

Blaxland, Chris

Clementi, Bill

Conley, Dan

Damm, Christopher

Dugery, Mike speaker

Goldberg, Alan

Goldberg, Paula

Hanson, Karen

Johnson, Joe

Kaupinen, Wesley

Khouri, Andrew

Kirk, David,

Koutlas, P.S.

Lindner, Marie

Martini, Jeffrey

Mitchell, Robin

Ogletree, Martin

Patterson, Joe

Reilly, Tom

Rodwell, John

Schina, Michael

Sharpe, Jim

Shickel, Tracy

Siegel, Marvin

Sparg, Brian

Suter, Stuart

Temeles, Gretchen

Thompson, Tom

Van der Kam, Peter

Warshafsky, Jordan

Zindulis, Joe



Good Company! Good Drink! Good Food! Good Program! Good Fun!


Site Navigation



Pharmaceutical Consulting Consortium International, Inc., or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2018



Tat Communication Inc